Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,688,572
+$1,134,581 QoQ
Shares Held
3,909
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,761
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $25,620,221 across 16 Drug Manufacturers - General names. LLY ranks #3 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,837 | $5,545,942 | |
| 2 | ABBV |
AbbVie Inc.
|
19,010 | $4,783,676 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,909 | $4,688,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,199 | $4,651,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,282 | $1,678,047 | |
| 6 | AMGN |
Amgen Inc
|
4,076 | $1,476,001 | |
| 7 | PFE |
Pfizer Inc
|
33,216 | $799,841 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,165 | $758,567 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,688,572 | 3,909 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,553,991 | 3,864 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,126,771 | 3,840 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,720,858 | 3,566 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,906,224 | 5,011 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,150,197 | 5,025 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $4,258,352 | 5,516 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,167,461 | 4,704 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,771,813 | 4,166 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,149,960 | 4,049 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,762,750 | 3,024 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,545,323 | 2,877 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,255,928 | 2,678 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $639,104 | 1,861 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $681,925 | 1,864 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $602,724 | 1,864 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $604,688 | 1,865 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $273,196 | 954 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $277,324 | 1,004 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $226,660 | 981 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $220,109 | 959 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $177,479 | 950 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $161,917 | 959 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $140,915 | 952 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $362,837 | 2,210 | Shares | Sole | 2020-09-28 | |
| 2020-03-31 | $306,571 | 2,210 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||